Cases & Deals

  • Home
  • Practices
  • Sanofi sells Dermik dermatology unit to Valeant Pharmaceuticals for $425 million

Share

Sanofi sells Dermik dermatology unit to Valeant Pharmaceuticals for $425 million

December 2011

Client(s) Sanofi

Jones Day advised Sanofi in the sale of its Dermik dermatology unit to Valeant Pharmaceuticals International Inc. for $425 million. Dermik has a significant presence in the medical dermatology market in the United States and Canada.

In addition to M&A representation, Jones Day provided intellectual property, antitrust, and employee benefits advice regarding this transaction.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.